These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 723448)

  • 1. Functional interaction between receptors for dopamine antagonists and GABA central receptors.
    Trabucchi M; Govoni S; Tonon GC; Spano PF
    Life Sci; 1978 Oct; 23(17-18):1751-6. PubMed ID: 723448
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra.
    Gale K
    Nature; 1980 Feb; 283(5747):569-70. PubMed ID: 7354838
    [No Abstract]   [Full Text] [Related]  

  • 3. GABA-receptors in the substantia nigra controlling cyclic-GMP in the cerebellar cortex.
    Biggio G; Corda MG; Casu M; Mulas ML; Gessa GL
    Adv Exp Med Biol; 1979; 123():419-27. PubMed ID: 229716
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Gale K; Casu M
    Mol Cell Biochem; 1981 Sep; 39():369-405. PubMed ID: 6118827
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition by apomorphine of the potassium-evoked release of [3H]-gamma-aminobutyric acid from the rat substantia nigra in vitro.
    Arbilla S; Kamal LA; Langer SZ
    Br J Pharmacol; 1981 Oct; 74(2):389-97. PubMed ID: 7317688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic receptor activity in substantia nigra in the mechanisms of autoregulation of striatal dopamine release.
    Groppetti A; Parenti M; Cattabeni F; Maggi A; De Angelis L; Monduzzi M; Racagni G
    Adv Biochem Psychopharmacol; 1978; 19():363-71. PubMed ID: 696464
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
    Di Chiara G; Morelli M; Porceddu ML; Gessa GL
    Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
    Morelli M; Porceddu ML; Imperato A; Di Chiara G
    Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished responses of nigral dopaminergic neurons to haloperidol and morphine following lesions in the striatum.
    Kondo Y; Iwatsubo K
    Brain Res; 1980 Jan; 181(1):237-40. PubMed ID: 7350960
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in benzodiazepine receptors following GABAergic denervation of substantia nigra.
    Biggio G; Corda MG; Lamberti C; Gessa GL
    Eur J Pharmacol; 1979 Sep; 58(2):215-6. PubMed ID: 499354
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3H-SCH 23390 binding sites in the rat substantia nigra: evidence for a presynaptic localization and innervation by dopamine.
    Porceddu ML; Giorgi O; Ongini E; Mele S; Biggio G
    Life Sci; 1986 Jul; 39(4):321-8. PubMed ID: 3526066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supersensitivity of substantia nigra pars reticulata neurons to GABAergic drugs after striatal lesions.
    Waszczak BL; Hume C; Walters JR
    Life Sci; 1981 May; 28(21):2411-20. PubMed ID: 6265730
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective antagonists of dopamine receptor subtypes differentially affect substance P levels in the striatum and substantia nigra.
    Oblin A; Zivkovic B; Bartholini G
    Brain Res; 1987 Sep; 421(1-2):387-90. PubMed ID: 2446703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Origin of GABA-ergic strio-nigral neurons as studied by kainate-induced lesions.
    Porceddu ML; Morelli M; Del Fiacco M; Di Chiara G
    Pharmacol Res Commun; 1980 Jul; 12(7):695-8. PubMed ID: 7403239
    [No Abstract]   [Full Text] [Related]  

  • 17. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of GABA receptors in the short-term activation of striatal tyrosine-3-monooxygenase elicited by neuroleptics.
    Guidotti A; Gale K
    Adv Biochem Psychopharmacol; 1977; 16():455-60. PubMed ID: 18893
    [No Abstract]   [Full Text] [Related]  

  • 19. GABA receptor binding in rat striatum: localization and effects of denervation.
    Campochiaro P; Schwarcz R; Coyle JT
    Brain Res; 1977 Nov; 136(3):501-11. PubMed ID: 922498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for the stimulation of rat brain dopamine receptors by ergometrine.
    Woodruff GN; Elkhawad AO; Crossman AR
    J Pharm Pharmacol; 1974 Jun; 26(6):455-6. PubMed ID: 4154992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.